Search CommunityWalk:


Valens Therapeutics, Inc.

1450 South Rolling Road
Baltimore, MD 21227, USA

Category: Pharmaceutical

Used in the following map:

Maryland Biotech Industry Map

Valens Therapeutics, Inc. is a pharmaceutical company involved in the development of the next generation of novel therapeutics to address important unmet medical needs. The company includes therapeutics to treat diseases caused by abnormal angiogenesis and infectious pathogens. The company's proprietary molecules target human proteins involved in abnormal vascular growth, pathological conditions of the eye, cancer, tumor growth, metastasis and other disease conditions and proteins from infectious pathogens including viruses and bacteria.

Valens Therapeutics's technology platform comprises class of compounds with physicochemical properties, highly stable, resistant to degradation by enzymes and stable folding structures that could be developed into drug candidates against several target areas including ophthalmology, oncology, neurology, inflammation and infectious diseases and also molecules capable of modifying disease state cell characteristics. The technology consists of conjugating several different proprietary molecules to a non-toxic, water soluble, safe, non-immunogenic and biocompatible polymer to create novel next generation multi-targeted therapeutics for the treatment of a variety of human diseases, for which there are no effective treatment drugs.

Valens in the area of ophthalmology, develops a product with characteristics not observed in the available ocular therapies for the treatment of ocular pathologies. Neovascularization in the eye causes a variety of diseases including macular degeneration, choroidal neovascularization, diabetic retinopathy and other eye pathologies. In the area of oncology it develops multi-targeted therapeutic for the treatment of pancreatic cancer. The company develops the next generation multi-targeted anti-HIV therapeutic vaccine for the treatment and prevention of HIV/AIDS in the area of infectious diseases.